pentobarbital will reduce the extent or effect of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic impact of elbasvir/grazoprevir could be lowered if coadministered with solid CYP3A inducers and is consequently contraindicated. pent